Navigation Links
Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
Date:9/25/2013

HAMBURG, Germany, September 25, 2013 /PRNewswire/ --

Indivumed GmbH ("Indivumed"), based in Hamburg, Germany, announces that 100% of all shares of Inostics GmbH and its Baltimore, US-based subsidiary Inostics Inc. ("Inostics"), have been sold to Sysmex Corporation (Headquarter in Kobe, Japan).

Inostics possesses advanced genetic testing technologies, such as ultra-sensitive digital PCR technology for detecting cancer cell DNA directly from blood - a "liquid biopsy" process as opposed to tissue testing. By acquiring this technology, Sysmex plans to develop on a global basis assay services that Inostics already provides. Sysmex's companion diagnostics activities in collaboration with pharmaceutical companies will be enhanced as well.

In 2008, following a five year collaboration with Dr. Bert Vogelstein and his team at Johns Hopkins University in Baltimore, MD, Indivumed and the scientists at Johns Hopkins University together founded Inostics GmbH in Hamburg, Germany, to commercialize the "BEAMing-Technology". "Having established a solid foundation to enable the rapid growth of Inostics, the overwhelming acceptance of this groundbreaking technology by pharmaceutical companies and the medical community demanded a global growth strategy and search for a strategic partner. We are delighted to have found with Sysmex the ideal partner for the next development phase," comments Prof. Hartmut Juhl, CEO of Indivumed and Inostics.

"With Sysmex, we expect achieving our goal to make Inostics technology the leading approach for DNA-based cancer diagnostics for the worldwide benefit of cancer patients. The fact that Sysmex has its European Headquarter in the Hamburg area facilitates a smooth transition and an undelayed continuation of Inostics business" says Dr. Frank Diehl, co-founder of Inostics, who continues to work for Inostics as Chief Scientific Officer and Managing Director.

Following the closing of the transaction, Indivumed will independently expand its tissue-based clinical research service business leveraging a comprehensive and very high quality tumor-biobank and its well-established prowess in the analysis of proteins and cancer pathways for drug development and patient diagnostics.

JMP Securities LLC acted as financial advisor and Freshfields Bruckhaus Deringer LLP served as legal counsel to Inostics and its shareholder in the transaction.

About Indivumed GmbH

Indivumed GmbH, a privately hold biotech company, was founded 2002 in Hamburg, Germany, to promote the development and clinical implementation of individual cancer therapies. Based on a highly standardized tumor biobank and a unique clinical infrastructure with clinical partners in Germany and the US, Indivumed offers a broad range of specialized research services to biopharmaceutical companies and academia and performs biomarker research and development. With its subsidiary IndivuTest GmbH, Indivumed provides high-quality-tissue based tumor analysis to patients and started an initiative with oncologists in Germany and the US to improve personalized cancer therapy strategies in the clinical routine.

For more information (also about Inostics and IndivuTest) please visit http://www.indivumed.com.

About Sysmex Corporation

Sysmex Corporation (Headquarter: Kobe, Japan), a listed company at the Tokyo Stock Exchange market, supports human health. Sysmex is an integrated company, developing and manufacturing the instruments, reagents and software that are needed for in-vitro diagnostics, and providing the necessary sales and support networks. Sysmex is expanding operations, augmenting traditional strength in hematology with non-hematology fields such as immunochemistry and hemostasis, as well as the life science field. Sysmex is leveraging its proprietary technologies to create new testing and diagnostic technologies that aim to ensure optimal healthcare for all.

For more information please visit http://www.sysmex.com.

Press contact:
Swantje Niphut
E-Mail: press@indivumed.com
Phone: +49(0)40-413383-0



'/>"/>
SOURCE Indivumed GmbH
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Geisinger Partners With Indivumed for Personalized Medicine Initiative
2. Pure Garcinia Cambogia Extract from Zen Health Labs Sells Out Three Weeks after its Launch on Amazon
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. Microsofts Surface Pro Tablet Makes its Debut and Sells Out Fast; the Company was One of the Few to Defy the Dows Loss Yesterday
5. Apama Medical, A Shifamed Portfolio Company, Closes $3.2M Series A-1 Financing Round
6. ParagonRx, An inVentiv Health Company, Names Former U.S. Food And Drug Administration Official To Position Of Chief Medical Officer
7. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
8. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
9. Nucletron, an Elekta company, to Debut New Flexitron Brachytherapy Afterloading Platform at 2013 American Brachytherapy Society Meeting
10. Accordant Health Services, a CVS Caremark Company, Receives URAC Case Management Accreditation
11. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2020)... ... June 25, 2020 , ... The Heritage Downtown Active Senior Living Apartment Homes ... With over 100,000 positive cases of the coronavirus in the United States to date, ... The Heritage Downtown, their family members, as well as the Walnut Creek community. ...
(Date:6/24/2020)... ... June 24, 2020 , ... The R3 Comprehensive Stem Cell Training ... two day courses offer providers a hands on approach to learning techniques for stem ... Live Stream for providers who wish to enroll remotely. , The comprehensive stem ...
(Date:6/23/2020)... ... June 23, 2020 , ... Healthcare Management Solutions, ... new website, which can be found at: https://hcmsllc.com/ . The healthcare and ... cutting-edge solutions — and this rebrand reflects HMS’ continued excellence and impressive evolution ...
Breaking Medicine Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to Improve ... Medicine at the University of Massachusetts Medical School- Baystate and Ann Gaffey, RN, ... SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in May ...
(Date:6/28/2020)... ... ... PathAI, a global provider of artificial intelligence (AI)-powered technology for use in pathology ... expression to assess response in patients treated with Bristol Myers Squibb’s PD-1 inhibitor, nivolumab ... (AACR) Annual Meeting. AACR was held June 22 to June 24. , The key ...
(Date:6/28/2020)... ... June 27, 2020 , ... ... the first online, full-day educational conference in the organization’s history. The online conference ... muscular dystrophy (FSHD), which was cancelled this year due to COVID-19. Nearly 300 ...
(Date:6/24/2020)... ... June 24, 2020 , ... Evolved Naturals, a new brand ... website at http://www.evolvednaturals.com The newly launched website showcases a variety of ... , and a comprehensive line of skincare & topical products . , Doug ...
(Date:6/24/2020)... (PRWEB) , ... June 24, 2020 , ... The world’s ... cost comparison survey that details which cell phones will be worth the most two ... brands on the market - iPhone, Samsung, Google, Sony and LG - and compared ...
Breaking Medicine News(10 mins):